GLP-1s Linked to Systemic Clinical Risk Reduction in Hidradenitis Suppurativa

[ad_1]

(MedPage Today) — Patients with hidradenitis suppurative (HS) and a history of GLP-1 receptor agonist use for diabetes or obesity had significantly lower rates of multiple cardiovascular events and mortality, a large retrospective cohort study…

[ad_2]

Source link : https://www.medpagetoday.com/dermatology/generaldermatology/122005

Author :

Publish date : 2026-07-01 15:14:00

Copyright for syndicated content belongs to the linked Source.